United Therapeutics Insider Sold Shares Worth $5,235,756, According to a Recent SEC Filing

Martine A Rothblatt, Director, Chairperson & Chief Executive Officer, on July 09, 2026, sold 9,500 shares in United Therapeutics (UTHR) for $5,235,756. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 668,728 common shares of the company, with 40,513 shares held directly and 628,215 controlled indirectly. SEC Filing: